The aim of this study is to find out whether inflammation markers including cardiac markers have predictive value in evaluation of pathogenesis of sepsis in neutropenic haematological patients.

Adult AML and ASCT patients with neutropenic fever. Observation of possible progress to severe sepsis or septic shock. Blood sample collection on days 0-3 (from the beginning of neutropenic fever).

Inclusion Criteria:

• diagnosis: acute myeloid leukaemia
• age under 70 years
• neutropenic fever

Exclusion Criteria:

• age above 70 years
• no neutropenic fever

Neutropenic patients in haematology ward having neutropenic fever with or without severe sepsis